AbolerIS Pharma

Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance, AbolerIS Pharma is developing novel and unique therapeutic approaches to finely regulate the immune system by inducing immune tolerance and preserving useful immune responses in inflammatory, autoimmune, and degenerative diseases.

Member type
- Company
Core Business
- Drug Development
Technology
- Therapeutic antibodies and fragments
Therapeutic Area
- Immunology
Size
- [11-50]

This combination does not exist.

Member type: Company

Core Business: Drug Development

Technology: Therapeutic antibodies and fragments

Therapeutic Area: Immunology

Size: [11-50]

AbolerIS Pharma

0.00 € 0.0 EUR 0.00 €

0.00 €